Harmony Biosciences Holdings ROCE Ratio 2011-2026 | HRMY

Annual ROCE Ratio Harmony Biosciences Holdings

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
20.45	23.16	29.65	20.2	23.05	5.81	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
29.65	5.81	20.39

Quarterly ROCE Ratio Harmony Biosciences Holdings

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
26.28	27.68	25.48	18.56	28.25	29.9	33.93	23.14	25.36	17.89	24.29	22.42	28.54	32.45	26.24	18.13	21.68	19.1	14.38	2.76	11.95	17.58	15.09	9.19	9.19	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
33.93	2.76	21.18

ROCE Ratio of other stocks in the Biotechnology industry

Issuer	ROCE Ratio	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	2.89	-	2.43 %	$ 254 M	Germany
Assembly Biosciences ASMB	-5.86	$ 28.49	0.11 %	$ 319 M	USA
Amphastar Pharmaceuticals AMPH	17.8	$ 19.61	0.59 %	$ 917 M	USA
Amarin Corporation plc AMRN	-10.92	$ 14.72	1.59 %	$ 6.11 B	Irlanda
Alexion Pharmaceuticals, Inc. ALXN	17.36	-	-	$ 40.3 B	USA
Genfit SA GNFT	-49.48	-	2.54 %	$ 160 B	France
Ascendis Pharma A/S ASND	-45.89	$ 221.08	-0.36 %	$ 5 B	Danmark
Biophytis SA BPTS	-325.06	-	-13.47 %	$ 169 M	France
Autolus Therapeutics plc AUTL	-161.2	$ 1.4	1.82 %	$ 357 M	Britain
Midatech Pharma plc MTP	-337.43	-	-18.52 %	$ 27.3 M	Britain
EyeGate Pharmaceuticals, Inc. EYEG	-61.36	-	-1.52 %	$ 24.7 M	USA
Axsome Therapeutics AXSM	-188.87	$ 155.38	-0.98 %	$ 7.73 B	USA
Applied Genetic Technologies Corporation AGTC	-60.13	-	-	$ 26.5 M	USA
ARCA biopharma ABIO	-23.06	-	1052.0 %	$ 415 M	USA
Aeterna Zentaris AEZS	-29.95	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	-180.78	-	-10.17 %	$ 12.2 K	USA
Acorda Therapeutics ACOR	167.74	-	-24.86 %	$ 820 K	USA
Albireo Pharma ALBO	-70.32	-	-0.23 %	$ 916 M	USA
Aileron Therapeutics ALRN	-119.71	-	10.36 %	$ 9.8 M	USA
Acasti Pharma ACST	-25.04	-	4.01 %	$ 150 M	Canada
Институт стволовых клеток человека ISKJ	15.18	-	-	-	Russia
Avenue Therapeutics ATXI	-403.4	-	-52.27 %	$ 4.45 M	USA
Adverum Biotechnologies ADVM	-196.79	-	-	$ 86.2 M	USA
Acer Therapeutics ACER	146.85	-	2.71 %	$ 14 M	USA
Advaxis ADXS	429.74	-	-9.65 %	$ 45.9 M	USA
BioMarin Pharmaceutical BMRN	6.73	$ 55.05	1.7 %	$ 10.6 B	USA
Ayala Pharmaceuticals AYLA	3412.47	-	-	$ 7.46 M	Israel
AbCellera Biologics ABCL	-16.8	$ 3.46	1.76 %	$ 1.03 B	Canada
Benitec Biopharma BNTC	-10.11	$ 10.92	-0.55 %	$ 449 M	USA
Atreca BCEL	-34.9	-	-11.76 %	$ 5.79 M	USA
BioDelivery Sciences International BDSI	19.77	-	-4.8 %	$ 255 M	USA
BeiGene, Ltd. BGNE	7.03	-	0.49 %	$ 251 B	Cayman-islands
Calithera Biosciences CALA	-1377.15	-	-10.95 %	$ 876 K	USA
Cara Therapeutics CARA	-212.83	-	-3.03 %	$ 260 M	USA
ChemoCentryx CCXI	-45.41	-	-	$ 3.74 B	USA
Heron Therapeutics HRTX	-17.71	$ 0.79	2.02 %	$ 132 M	USA
Bellerophon Therapeutics BLPH	-883.35	-	-74.18 %	$ 955 K	USA
Checkpoint Therapeutics CKPT	444.94	-	-	$ 169 M	USA
Clovis Oncology CLVS	80.97	-	-7.23 %	$ 13 M	USA
Aeglea BioTherapeutics AGLE	-29.3	-	-	$ 1.01 B	USA
CureVac N.V. CVAC	-51.5	-	-	$ 867 M	Germany
Compugen Ltd. CGEN	23.38	$ 2.13	2.15 %	$ 199 M	Israel
Coherus BioSciences CHRS	-296.87	$ 1.58	3.62 %	$ 185 M	USA
Akero Therapeutics AKRO	-38.05	-	-	$ 3.67 B	USA
Arbutus Biopharma Corporation ABUS	-73.67	$ 4.47	5.54 %	$ 742 M	Canada
Akouos AKUS	-37.16	-	0.23 %	$ 488 M	USA
AIkido Pharma AIKI	-28.92	-	1.93 %	$ 17.4 M	USA
Cyclacel Pharmaceuticals CYCC	552.16	-	-5.98 %	$ 34.1 M	USA
Decibel Therapeutics DBTX	-78.19	-	-	$ 123 M	USA